Q2 2026 · Form 13F Ledger数据来源:SEC EDGAR  
H

HOLDER.TOP

谁持有什么——美股机构持仓的季度账本。
EN · 简 · 繁
机构 / Lion Point Capital, LP
Form 13F · Q2 2026

Lion Point Capital, LP

CIK 1643354申报日 2026-08-1413F-HR 在 EDGAR 查看原始申报 ↗
$2091万
申报组合市值
35
持仓数量
12
Quarters on record
Top 50
持仓数量

Lion Point Capital, LP——持仓

共 35 个持仓中的前 35 名,按申报市值排名。股数变动与上一季度对比。
#证券股数股数环比市值占其组合
1CUE Cue Biopharma Inc52,928—$167万8.0%
2PRAX Praxis Precision Medicines I4,450+0.0%$149万7.1%
3MLTX Moonlake Immunotherapeutics67,500+0.0%$131万6.3%
4FENC Fennec Pharmaceuticals Inc112,434+0.0%$121万5.8%
5RPRX Royalty Pharma Plc21,400+0.0%$120万5.7%
6CMPS Compass Pathways Plc80,000+0.0%$113万5.4%
7MIST Milestone Pharmaceuticals In820,000+0.0%$110万5.3%
8BNTC Benitec Biopharma Inc62,000+0.0%$83万4.0%
9SNDX Syndax Pharmaceuticals Inc36,000+0.0%$79万3.8%
10BHVN Biohaven Ltd51,700+0.0%$77万3.7%
11GERN Geron Corp578,000+0.0%$74万3.5%
12QURE Uniqure Nv14,700+0.0%$68万3.2%
13ARDX Ardelyx Inc128,650+0.0%$66万3.1%
14LNTH Lantheus Hldgs Inc5,500+0.0%$61万2.9%
15IRON Disc Medicine Inc8,100+0.0%$59万2.8%
16SRPT Sarepta Therapeutics Inc28,500+0.0%$51万2.4%
17HUMA Humacyte Inc650,000+0.0%$51万2.4%
18KURA Kura Oncology Inc46,000+0.0%$50万2.4%
19VTRS Viatris Inc27,700+0.0%$44万2.1%
20DYN Dyne Therapeutics Inc18,000+0.0%$40万1.9%
21BBIO Bridgebio Pharma Inc5,000+0.0%$37万1.8%
22EWTX Edgewise Therapeutics Inc9,100+0.0%$37万1.8%
23PCRX Pacira Biosciences Inc13,500+0.0%$34万1.6%
24RGNX Regenxbio Inc26,600+0.0%$32万1.5%
25RCKT Rocket Pharmaceuticals Inc86,000+0.0%$29万1.4%
26JANX Janux Therapeutics Inc19,000+0.0%$29万1.4%
27MLYS Mineralys Therapeutics Inc10,500+0.0%$28万1.4%
28GHRS Gh Research Plc10,200+0.0%$27万1.3%
29MCRB Seres Therapeutics Inc31,570+0.0%$25万1.2%
30AZTA Azenta Inc9,700+0.0%$25万1.2%
31JSPR Jasper Therapeutics Inc465,000+0.0%$20万0.9%
32INVA Innoviva Inc8,200+0.0%$19万0.9%
33IPHA Innate Pharma S A81,151+0.0%$15万0.7%
34ARQT Arcutis Biotherapeutics Inc5,250+0.0%$14万0.7%
35SPRB Spruce Biosciences Inc1,000+0.0%$5万0.3%
来源:经 SEC EDGAR 的 Form 13F 申报。持仓截至 2026 年 6 月 30 日。期权(看涨/看跌)不计入股数。